New York’s Medicaid program is moving forward with a dangerous policy change that would bundle phosphate-lowering therapies — lifesaving medications for kidney patients — into a single Ambulatory Patient Group (APG) payment rate.If implemented, this policy would strip...

GLP-1 medications like Ozempic, Wegovy, and Mounjaro are helping millions of Americans manage diabetes and obesity. But alongside their success, unregulated and counterfeit products are putting patients at serious risk. Across the country, people are being exposed to...